Capitol News Alliance pored through the more than 600 measures debated at the Capitol this year to highlight the most notable ...

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the ...